171 related articles for article (PubMed ID: 34631264)
61. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality.
Davenport DL; Xenos ES; Hosokawa P; Radford J; Henderson WG; Endean ED
J Vasc Surg; 2009 Jan; 49(1):140-7, 147.e1; discussion 147. PubMed ID: 19028047
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
[TBL] [Abstract][Full Text] [Related]
63. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
[TBL] [Abstract][Full Text] [Related]
64. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
65. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
66. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
67. Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.
Weinlich G; Bitterlich W; Mayr V; Fritsch PO; Zelger B
Br J Dermatol; 2003 Sep; 149(3):535-41. PubMed ID: 14510986
[TBL] [Abstract][Full Text] [Related]
68. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
69. Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.
Lucarini G; Simonetti O; Lazzarini R; Giantomassi F; Goteri G; Offidani A
Melanoma Res; 2020 Oct; 30(5):433-442. PubMed ID: 32516239
[TBL] [Abstract][Full Text] [Related]
70. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
[TBL] [Abstract][Full Text] [Related]
71. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
72. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
[No Abstract] [Full Text] [Related]
73. Number of levels required to assess Breslow thickness in cutaneous invasive melanoma: An observational study.
Bishop J; Tallon B
J Cutan Pathol; 2019 Nov; 46(11):819-822. PubMed ID: 31270835
[TBL] [Abstract][Full Text] [Related]
74. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
75. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
76. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
77. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.
Piñero-Madrona A; Ruiz-Merino G; Cerezuela Fuentes P; Martínez-Barba E; Rodríguez-López JN; Cabezas-Herrera J
Clin Transl Oncol; 2019 Oct; 21(10):1348-1356. PubMed ID: 30783917
[TBL] [Abstract][Full Text] [Related]
78. Body mass index strongly impacts the diagnosis and incidence of heparin-induced thrombocytopenia in the surgical intensive care unit.
Bloom MB; Zaw AA; Hoang DM; Mason R; Alban RF; Chung R; Melo N; Volod O; Ley EJ; Margulies DR
J Trauma Acute Care Surg; 2016 Mar; 80(3):398-403; discussion 403-4. PubMed ID: 26906645
[TBL] [Abstract][Full Text] [Related]
79. A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience.
Reginelli A; Belfiore MP; Russo A; Turriziani F; Moscarella E; Troiani T; Brancaccio G; Ronchi A; Giunta E; Sica A; Iovino F; Ciardiello F; Franco R; Argenziano G; Grassi R; Cappabianca S
Curr Radiopharm; 2020; 13(1):48-55. PubMed ID: 31589132
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
